Tag: balloon catheters market size

The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.

How Does The Forecasted Market Size Of The Balloon Catheters Market Compare Between 2026 And 2030?

The balloon catheters market size has experienced considerable growth in recent years. It is projected to expand from $4.11 billion in 2025 to $4.32 billion in 2026, exhibiting a compound annual growth rate (CAGR) of 5.2%. This historical growth can be attributed to factors such as the rising prevalence of cardiovascular disease, increased adoption of angioplasty procedures, the expansion of catheterization laboratories, the availability of advanced interventional cardiology devices, and growing clinical expertise in endovascular treatments.

The balloon catheters market is poised for robust expansion over the coming years, with projections indicating it will reach $5.25 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 5.0%. This anticipated growth during the forecast period stems from factors such as enhanced innovation in balloon catheter coatings, a surge in demand for outpatient interventional procedures, the broadening of minimally invasive treatment applications, the rising uptake of precision-guided devices, and increased investment in cardiovascular device research and development. Key trends identified for this period encompass the growing acceptance of drug-eluting balloon catheters, an increasing need for minimally invasive cardiovascular procedures, the expanded utilization of high-pressure and scoring balloons, the enlargement of treatment options for peripheral artery disease, and a heightened emphasis on procedural accuracy and patient safety.

Download A Free Sample Report For Comprehensive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=20717&type=smp

What Major Growth Factors Are Impacting The Balloon Catheters Market?

The balloon catheters market is anticipated to experience growth driven by the increasing adoption of minimally invasive surgeries. These procedures, often referred to as MIS, involve minimal incisions rather than extensive cuts, reducing the need for significant bodily openings. The surge in minimally invasive surgeries can be attributed to benefits such as shorter recovery periods, reduced complication risks, and less post-operative pain, further supported by technological advancements and the rise of outpatient care. Balloon catheters play a vital role in enhancing these surgical techniques by improving their precision, safety, and patient comfort, simultaneously contributing to shorter recovery times and hospital stays. As an illustration, Intuitive Surgical Inc., a US-based manufacturer specializing in robotic products, reported in January 2024 the placement of 415 da Vinci surgical systems – robotic systems employing a minimally invasive approach – during the fourth quarter of 2023. This figure represents a notable 12% increase compared to 2022. Consequently, the expanding use of minimally invasive surgeries is a key factor propelling the growth within the balloon catheters market.

How Does Segment Analysis Break Down The Balloon Catheters Market Structure?

The balloon catheters market covered in this report is segmented –

1) By Procedure Type: Percutaneous Transluminal Coronary Angioplasty (PTCA) Balloon Catheters, Chronic Total Occlusion (CTO) Balloon Catheters

2) By Product Type: Normal Balloon Catheter, Drug Eluting Balloon Catheter, Cutting Balloon Catheter, Stent Graft Balloon Catheter, Scoring Balloon Catheter

3) By Distribution Channel: Direct Tender, Third Party Distribution, Other Distribution Channels

4) By Application: Coronary Artery Disease, Peripheral Artery Disease, Other Applications

5) By End User: Hospitals, Specialty Centers, Ambulatory Surgery Centers, Other End Users

Subsegments:

1) By Percutaneous Transluminal Coronary Angioplasty (PTCA) Balloon Catheters: Semi-Compliant Balloon Catheters, Non-Compliant Balloon Catheters

2) By Chronic Total Occlusion (CTO) Balloon Catheters: High-Pressure CTO Balloon Catheters, Low-Profile CTO Balloon Catheters

What Trends Are Influencing The Balloon Catheters Market Outlook?

Major companies engaged in the balloon catheters market are concentrating on creating solutions for mechanical thrombectomy (MT) procedures, with the aim of optimizing blood clot removal through localized control of blood flow during these interventions. Mechanical thrombectomy (MT) is a minimally invasive medical technique utilized to extract blood clots from blood vessels, typically in situations involving ischemic stroke. For instance, in September 2024, CERENOVUS, the neurovascular division of Johnson & Johnson Medical Devices Companies, introduced the EMBOGUARD Balloon Guide Catheter in Europe. This device is specifically engineered for endovascular procedures, including the treatment of acute ischemic stroke. The EMBOGUARD catheter improves clot removal by regulating local blood flow during mechanical thrombectomy procedures. Its deployment has been linked to higher first-pass recanalization rates, shorter procedure durations, and a reduced chance of clot fragments causing distal emboli, which can trigger new ischemic events. The EMBOGUARD Balloon Guide Catheter is integrated into the CERENOVUS Stroke Solutions portfolio, a collection of technologies developed to support physicians in executing mechanical thrombectomy procedures.

Who Are The Prominent Players Across The Balloon Catheters Market?

Major companies operating in the balloon catheters market are Cardinal Health Inc., Johnson & Johnson, Abbott Laboratories, Medtronic plc, Boston Scientific Corporation, Lepu Medical Technology, B. Braun Melsungen AG, Terumo Corporation, Teleflex Incorporated, Cook Medical Inc., Biotronik SE & Co. KG, Merit Medical Systems Inc., Asahi Intecc Co. Ltd., Freudenberg Medical LLC, Biomerics, AngioDynamics Inc., Endologix Inc., Raumedic AG, Otsuka Pharmaceutical Factory Inc., AngioScore Inc., CardioFlow, Endocor GmbH, MicroPort Scientific Corporation, Eureka Medical Inc., Neovasc Inc.

Access The Complete Balloon Catheters Market Report:

https://www.thebusinessresearchcompany.com/report/balloon-catheters-global-market-report

Which Area Represents The Largest Portion Of The Balloon Catheters Market?

North America was the largest region in the balloon catheters market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the balloon catheters market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Access Balloon Catheters Market Report for Deeper Competitive Insights

https://www.thebusinessresearchcompany.com/customise?id=20717&type=smp

Browse Through More Reports Similar to the Global Balloon Catheters Market 2026, By The Business Research Company

Rehabilitation Equipment Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/rehabilitation-equipment-global-market-report

Rehabilitation Robotics Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/rehabilitation-robotics-global-market-report

Medical Rehabilitation Services Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/medical-rehabilitation-services-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas: +1 310-496-7795

Asia: +44 7882 955267 & +91 8897263534

Europe: +44 7882 955267

Email us at: marketing@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.

What Is The Forecasted Market Size Trajectory Of The Complicated Urinary Tract Infection Treatment Market From 2026 To 2030?

The complicated urinary tract infection treatment market size has seen robust growth in recent years. This market is expected to increase from $9.44 billion in 2025 to $10.04 billion in 2026, registering a compound annual growth rate (CAGR) of 6.4%. Historically, this expansion can be linked to the rising incidence of catheter-associated infections, increasing antibiotic resistance, an expanding aging population, developing hospital infrastructure, and improved diagnosis of chronic urinary disorders.

The complicated urinary tract infection treatment market size is anticipated to demonstrate substantial growth in the upcoming years. It is projected to expand to $12.74 billion in 2030, achieving a compound annual growth rate (CAGR) of 6.1%. This expansion during the forecast period is driven by factors such as the development of innovative antibiotics, an increase in the immunocompromised patient population, wider adoption of outpatient infusion therapies, rising healthcare expenditures, and enhanced pathogen identification technologies. Prominent trends throughout this period include the optimization of empiric therapy, an increase in the use of broad-spectrum antibiotics, a rise in hospitalizations for complicated UTIs, a growing preference for combination drug therapies, and the expansion of hospital pharmacy-based dispensing.

Access Your Free Sample Report For In-Depth Market Analysis:

https://www.thebusinessresearchcompany.com/report/complicated-urinary-tract-infection-treatment-global-market-report

Which Drivers Are Supporting The Complicated Urinary Tract Infection Treatment Market Growth?

The increasing occurrence of chronic kidney diseases is anticipated to boost the expansion of the complicated urinary tract infection treatment market in the future. Chronic kidney disease (CKD) represents a progressive, enduring ailment marked by a slow decline in kidney function across a period. This growing prevalence of Chronic kidney disease (CKD) primarily stems from rising rates of diabetes and hypertension, coupled with an aging demographic and lifestyle elements like obesity and smoking. Treatment for complicated urinary tract infections aids chronic kidney disease (CKD) patients by averting serious infections, including pyelonephritis, which could intensify kidney harm, deteriorate renal capabilities, and hasten the advancement of chronic kidney disease, thereby lowering the likelihood of subsequent complications and hospital admissions. As an illustration, figures from June 2024, provided by the Australian Institute of Health and Welfare, an Australia-based government agency, indicated that in 2023, chronic kidney disease accounted for 1.1% of the total disease burden in Australia. Consequently, the growing frequency of chronic kidney diseases acts as a primary driver for the complicated urinary tract infection treatment market.

Which Segment Classifications Are Used In The Complicated Urinary Tract Infection Treatment Market Segment Analysis?

The complicated urinary tract infection treatment market covered in this report is segmented –

1) By Drug Class: Penicillin And Combinations, Quinolones, Cephalosporin, Azoles And Amphotericin B, Nitro Furans

2) By Distribution Channel: Hospital Pharmacies, Gynecology And Urology Clinics, Drug Stores

3) By Application: Urethritis, Cystitis, Pyelonephritis

Subsegments:

1) By Penicillin And Combinations: Aminopenicillins, Beta-Lactamase Inhibitor Combinations

2) By Quinolones: Fluoroquinolones, Non-Fluoroquinolones

3) By Cephalosporin: First-Generation Cephalosporins, Second-Generation Cephalosporins, Third-Generation Cephalosporins, Fourth-Generation Cephalosporins, Fifth-Generation Cephalosporins

4) By Azoles And Amphotericin B: Triazoles, Imidazoles, Polyene Antifungals

5) By Nitrofurans: Nitrofurantoin, Furazolidone

Which Trends Are Expected To Impact The Complicated Urinary Tract Infection Treatment Market?

Companies within the complicated urinary tract infection treatment market are concentrating on developing novel antibiotics to combat antibiotic resistance, aiming to enhance treatment efficacy and address emerging multidrug-resistant pathogens. Anti-infective therapies for complicated urinary tract infection treatment involve employing targeted antibiotics or antimicrobial agents to eliminate or control infections, particularly in severe cases where kidney involvement is present. For example, in February 2024, Allecra Therapeutics, a Germany-based biopharmaceutical company, announced the U.S. Food and Drug Administration (FDA) approval of EXBLIFEP (cefepime/enmetazobactam) for treating complicated urinary tract infections (cUTIs) in adults. The company also secured a five-year marketing exclusivity extension under the GAIN Act, which incentivizes the development of new anti-infective therapies. A study demonstrated that 79.1% of patients treated with cefepime/enmetazobactam achieved a composite response (clinical cure and microbiological eradication) compared to 58.9% of those treated with piperacillin/tazobactam.

Which Firms Are Contributing To The Complicated Urinary Tract Infection Treatment Market Ecosystem?

Major companies operating in the complicated urinary tract infection treatment market are Pfizer Inc., Merck & Co. Inc., AbbVie Inc., AstraZeneca PLC, Fresenius Kabi AG, GlaxoSmithKline plc, bioMérieux SA, Shionogi & Co. Ltd., Cipla Limited, Santen Pharmaceutical Co. Ltd., Orchid Pharma Limited, Melinta Therapeutics Inc., Spero Therapeutics Inc., Nabriva Therapeutics AG, Venatorx Pharmaceuticals Inc., Recce Pharmaceuticals Ltd, MerLion Pharmaceuticals Pte. Ltd., Entasis Therapeutics Holdings Inc., Allecra Therapeutics GmbH, Allergan Inc.

Get The Full Complicated Urinary Tract Infection Treatment Market Report:

https://www.thebusinessresearchcompany.com/report/complicated-urinary-tract-infection-treatment-global-market-report

Which Region Leads The Complicated Urinary Tract Infection Treatment Market In Terms Of Market Share?

North America was the largest region in the complicated urinary tract infection treatment market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the complicated urinary tract infection treatment market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Complicated Urinary Tract Infection Treatment Market Report For Competitive Insights:

https://www.thebusinessresearchcompany.com/report/complicated-urinary-tract-infection-treatment-global-market-report

Browse Through More Reports Similar to the Global Complicated Urinary Tract Infection Treatment Market 2026, By The Business Research Company

Chlamydia Infection Treatment Market Report 2026

https://www.thebusinessresearchcompany.com/report/chlamydia-infection-treatment-global-market-report

Uncomplicated Urinary Tract Infection Treatment Market Report 2026

https://www.thebusinessresearchcompany.com/report/uncomplicated-urinary-tract-infection-treatment-global-market-report

Pediatric Bladder Treatment Market Report 2026

https://www.thebusinessresearchcompany.com/report/pediatric-bladder-treatment-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.

What Is The Projected Increase In Market Value Of The Balloon Catheters Market During 2026–2030?

The balloon catheters market has experienced substantial growth in recent years. Its value is anticipated to rise from $4.11 billion in 2025 to $4.32 billion in 2026, exhibiting a compound annual growth rate (CAGR) of 5.2%. This historical expansion can be ascribed to several factors, including the increasing prevalence of cardiovascular disease, the wider acceptance of angioplasty procedures, the expansion of catheterization laboratories, the availability of sophisticated interventional cardiology devices, and the developing clinical expertise in endovascular treatments.

The balloon catheters market is set for robust expansion over the next few years. It is projected to climb to $5.25 billion by 2030, achieving a compound annual growth rate (CAGR) of 5.0%. This growth during the forecast period is fueled by increasing innovation in balloon catheter coatings, a rising demand for outpatient interventional procedures, the broadening scope of minimally invasive treatment indications, the growing adoption of precision-guided devices, and an escalation in investment in cardiovascular device R&D. Noteworthy trends for the forecast period include the expanding acceptance of drug-eluting balloon catheters, a growing need for minimally invasive cardiovascular procedures, increased utilization of high-pressure and scoring balloons, the diversification of peripheral artery disease treatments, and an enhanced focus on procedural precision and safety.

Access Your Free Sample Report For In-Depth Market Analysis:

https://www.thebusinessresearchcompany.com/report/balloon-catheters-global-market-report

Which Key Factors Are Driving The Balloon Catheters Market Growth?

The expanding use of minimally invasive surgeries is anticipated to drive the expansion of the balloon catheters market in the coming years. Minimally invasive surgeries (MIS) involve surgical operations conducted with tiny incisions, thereby decreasing the need for large cuts or openings. The rise in minimally invasive surgeries (MIS) can be attributed to shorter recovery periods, reduced complication risks, and less pain, alongside advancements in technology and the rise of outpatient procedures. Balloon catheters are vital for amplifying the advantages of minimally invasive surgeries by boosting the accuracy, safety, and patient comfort of procedures, simultaneously shortening recovery periods and hospital stays. As an illustration, Intuitive Surgical Inc., a US-based robotic product manufacturer, disclosed in January 2024 that it had deployed 415 da Vinci surgical systems, which are robotic surgical systems employing a minimally invasive approach, during the fourth quarter of 2023, marking a 12% rise compared to 2022. Consequently, the growing embrace of minimally invasive surgeries fuels the growth within the balloon catheters market.

Which Segment Classifications Are Used In The Balloon Catheters Market Segment Analysis?

The balloon catheters market covered in this report is segmented –

1) By Procedure Type: Percutaneous Transluminal Coronary Angioplasty (PTCA) Balloon Catheters, Chronic Total Occlusion (CTO) Balloon Catheters

2) By Product Type: Normal Balloon Catheter, Drug Eluting Balloon Catheter, Cutting Balloon Catheter, Stent Graft Balloon Catheter, Scoring Balloon Catheter

3) By Distribution Channel: Direct Tender, Third Party Distribution, Other Distribution Channels

4) By Application: Coronary Artery Disease, Peripheral Artery Disease, Other Applications

5) By End User: Hospitals, Specialty Centers, Ambulatory Surgery Centers, Other End Users

Subsegments:

1) By Percutaneous Transluminal Coronary Angioplasty (PTCA) Balloon Catheters: Semi-Compliant Balloon Catheters, Non-Compliant Balloon Catheters

2) By Chronic Total Occlusion (CTO) Balloon Catheters: High-Pressure CTO Balloon Catheters, Low-Profile CTO Balloon Catheters

Which Trends Are Guiding The Direction Of The Balloon Catheters Market?

Major companies in the balloon catheters market are concentrating on developing solutions for mechanical thrombectomy (MT) procedures to optimize the removal of blood clots by managing local blood flow during these interventions. Mechanical thrombectomy (MT) is a minimally invasive medical procedure used for extracting blood clots from blood vessels, typically in instances of ischemic stroke. For example, in September 2024, CERENOVUS, a neurovascular division of Johnson & Johnson Medical Devices Companies, introduced the EMBOGUARD Balloon Guide Catheter in Europe. This device is engineered for endovascular procedures, which include the treatment of acute ischemic stroke. The EMBOGUARD catheter enhances clot removal through localized blood flow control during mechanical thrombectomy procedures. Its implementation has been associated with elevated first-pass recanalization rates, shortened procedure times, and a reduced probability of clot fragments causing distal emboli, which could lead to new ischemic events. The EMBOGUARD Balloon Guide Catheter belongs to the CERENOVUS Stroke Solutions portfolio, a collection of technologies designed to aid physicians in performing mechanical thrombectomy procedures.

Which Firms Are Contributing To The Balloon Catheters Market Ecosystem?

Major companies operating in the balloon catheters market are Cardinal Health Inc., Johnson & Johnson, Abbott Laboratories, Medtronic plc, Boston Scientific Corporation, Lepu Medical Technology, B. Braun Melsungen AG, Terumo Corporation, Teleflex Incorporated, Cook Medical Inc., Biotronik SE & Co. KG, Merit Medical Systems Inc., Asahi Intecc Co. Ltd., Freudenberg Medical LLC, Biomerics, AngioDynamics Inc., Endologix Inc., Raumedic AG, Otsuka Pharmaceutical Factory Inc., AngioScore Inc., CardioFlow, Endocor GmbH, MicroPort Scientific Corporation, Eureka Medical Inc., Neovasc Inc.

Get The Full Balloon Catheters Market Report:

https://www.thebusinessresearchcompany.com/report/balloon-catheters-global-market-report

Which Region Leads The Balloon Catheters Market In Overall Market Size?

North America was the largest region in the balloon catheters market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the balloon catheters market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Balloon Catheters Market Report For Competitive Insights:

https://www.thebusinessresearchcompany.com/report/balloon-catheters-global-market-report

Browse Through More Reports Similar to the Global Balloon Catheters Market 2026, By The Business Research Company

Deflectable Catheters Market Report 2026

https://www.thebusinessresearchcompany.com/report/deflectable-catheters-global-market-report

Pta Balloon Catheter Market Report 2026

https://www.thebusinessresearchcompany.com/report/pta-balloon-catheter-global-market-report

Catheters Market Report 2026

https://www.thebusinessresearchcompany.com/report/catheters-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.

What Is The Projected Increase In Market Value Of The Balloon Catheters Market During 2026–2030?

The balloon catheters market has experienced substantial growth in recent years. Its value is anticipated to rise from $4.11 billion in 2025 to $4.32 billion in 2026, exhibiting a compound annual growth rate (CAGR) of 5.2%. This historical expansion can be ascribed to several factors, including the increasing prevalence of cardiovascular disease, the wider acceptance of angioplasty procedures, the expansion of catheterization laboratories, the availability of sophisticated interventional cardiology devices, and the developing clinical expertise in endovascular treatments.

The balloon catheters market is set for robust expansion over the next few years. It is projected to climb to $5.25 billion by 2030, achieving a compound annual growth rate (CAGR) of 5.0%. This growth during the forecast period is fueled by increasing innovation in balloon catheter coatings, a rising demand for outpatient interventional procedures, the broadening scope of minimally invasive treatment indications, the growing adoption of precision-guided devices, and an escalation in investment in cardiovascular device R&D. Noteworthy trends for the forecast period include the expanding acceptance of drug-eluting balloon catheters, a growing need for minimally invasive cardiovascular procedures, increased utilization of high-pressure and scoring balloons, the diversification of peripheral artery disease treatments, and an enhanced focus on procedural precision and safety.

Access Your Free Sample Report For In-Depth Market Analysis:

https://www.thebusinessresearchcompany.com/report/balloon-catheters-global-market-report

Which Key Factors Are Driving The Balloon Catheters Market Growth?

The expanding use of minimally invasive surgeries is anticipated to drive the expansion of the balloon catheters market in the coming years. Minimally invasive surgeries (MIS) involve surgical operations conducted with tiny incisions, thereby decreasing the need for large cuts or openings. The rise in minimally invasive surgeries (MIS) can be attributed to shorter recovery periods, reduced complication risks, and less pain, alongside advancements in technology and the rise of outpatient procedures. Balloon catheters are vital for amplifying the advantages of minimally invasive surgeries by boosting the accuracy, safety, and patient comfort of procedures, simultaneously shortening recovery periods and hospital stays. As an illustration, Intuitive Surgical Inc., a US-based robotic product manufacturer, disclosed in January 2024 that it had deployed 415 da Vinci surgical systems, which are robotic surgical systems employing a minimally invasive approach, during the fourth quarter of 2023, marking a 12% rise compared to 2022. Consequently, the growing embrace of minimally invasive surgeries fuels the growth within the balloon catheters market.

Which Segment Classifications Are Used In The Balloon Catheters Market Segment Analysis?

The balloon catheters market covered in this report is segmented –

1) By Procedure Type: Percutaneous Transluminal Coronary Angioplasty (PTCA) Balloon Catheters, Chronic Total Occlusion (CTO) Balloon Catheters

2) By Product Type: Normal Balloon Catheter, Drug Eluting Balloon Catheter, Cutting Balloon Catheter, Stent Graft Balloon Catheter, Scoring Balloon Catheter

3) By Distribution Channel: Direct Tender, Third Party Distribution, Other Distribution Channels

4) By Application: Coronary Artery Disease, Peripheral Artery Disease, Other Applications

5) By End User: Hospitals, Specialty Centers, Ambulatory Surgery Centers, Other End Users

Subsegments:

1) By Percutaneous Transluminal Coronary Angioplasty (PTCA) Balloon Catheters: Semi-Compliant Balloon Catheters, Non-Compliant Balloon Catheters

2) By Chronic Total Occlusion (CTO) Balloon Catheters: High-Pressure CTO Balloon Catheters, Low-Profile CTO Balloon Catheters

Which Trends Are Guiding The Direction Of The Balloon Catheters Market?

Major companies in the balloon catheters market are concentrating on developing solutions for mechanical thrombectomy (MT) procedures to optimize the removal of blood clots by managing local blood flow during these interventions. Mechanical thrombectomy (MT) is a minimally invasive medical procedure used for extracting blood clots from blood vessels, typically in instances of ischemic stroke. For example, in September 2024, CERENOVUS, a neurovascular division of Johnson & Johnson Medical Devices Companies, introduced the EMBOGUARD Balloon Guide Catheter in Europe. This device is engineered for endovascular procedures, which include the treatment of acute ischemic stroke. The EMBOGUARD catheter enhances clot removal through localized blood flow control during mechanical thrombectomy procedures. Its implementation has been associated with elevated first-pass recanalization rates, shortened procedure times, and a reduced probability of clot fragments causing distal emboli, which could lead to new ischemic events. The EMBOGUARD Balloon Guide Catheter belongs to the CERENOVUS Stroke Solutions portfolio, a collection of technologies designed to aid physicians in performing mechanical thrombectomy procedures.

Which Firms Are Contributing To The Balloon Catheters Market Ecosystem?

Major companies operating in the balloon catheters market are Cardinal Health Inc., Johnson & Johnson, Abbott Laboratories, Medtronic plc, Boston Scientific Corporation, Lepu Medical Technology, B. Braun Melsungen AG, Terumo Corporation, Teleflex Incorporated, Cook Medical Inc., Biotronik SE & Co. KG, Merit Medical Systems Inc., Asahi Intecc Co. Ltd., Freudenberg Medical LLC, Biomerics, AngioDynamics Inc., Endologix Inc., Raumedic AG, Otsuka Pharmaceutical Factory Inc., AngioScore Inc., CardioFlow, Endocor GmbH, MicroPort Scientific Corporation, Eureka Medical Inc., Neovasc Inc.

Get The Full Balloon Catheters Market Report:

https://www.thebusinessresearchcompany.com/report/balloon-catheters-global-market-report

Which Region Leads The Balloon Catheters Market In Overall Market Size?

North America was the largest region in the balloon catheters market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the balloon catheters market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Balloon Catheters Market Report For Competitive Insights:

https://www.thebusinessresearchcompany.com/report/balloon-catheters-global-market-report

Browse Through More Reports Similar to the Global Balloon Catheters Market 2026, By The Business Research Company

Deflectable Catheters Market Report 2026

https://www.thebusinessresearchcompany.com/report/deflectable-catheters-global-market-report

Pta Balloon Catheter Market Report 2026

https://www.thebusinessresearchcompany.com/report/pta-balloon-catheter-global-market-report

Catheters Market Report 2026

https://www.thebusinessresearchcompany.com/report/catheters-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.

What Market Value Is Anticipated For The Balloon Catheters Market Over The Period 2026–2030?

The balloon catheters market has shown substantial growth in recent years. It is projected to expand from $4.11 billion in 2025 to $4.32 billion in 2026, achieving a compound annual growth rate (CAGR) of 5.2%. The historical expansion of this market can be attributed to the increasing prevalence of cardiovascular diseases, the greater adoption of angioplasty procedures, the expansion of catheterization laboratories, the availability of sophisticated interventional cardiology devices, and the growing clinical expertise in endovascular treatments.

The balloon catheters market is poised for significant expansion over the next few years, with its size expected to reach $5.25 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 5.0%. This growth is attributable to several factors, including increasing innovation in balloon catheter coatings, a rising demand for outpatient interventional procedures, the expansion of indications for minimally invasive treatments, growing adoption of precision-guided devices, and increased investment in cardiovascular device research and development. Key trends anticipated during this period encompass the greater adoption of drug-eluting balloon catheters, an increase in demand for minimally invasive cardiovascular procedures, the expanding use of high-pressure and scoring balloons, the broadening of peripheral artery disease treatments, and an enhanced focus on procedural precision and safety.

Download the Free Sample Report to Explore Key Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=20717&type=smp

Which Economic Or Industry Drivers Are Impacting The Balloon Catheters Market?

The increasing adoption of minimally invasive surgeries is poised to boost the growth of the balloon catheters market. Minimally invasive surgeries (MIS) are surgical interventions performed with minimal incisions, reducing the need for significant cuts or open procedures. The rise in minimally invasive surgeries is attributed to faster recovery times, a lower risk of complications, and less pain, further aided by technological advancements and the shift towards outpatient procedures. Balloon catheters play a pivotal role in augmenting the advantages of minimally invasive surgeries by improving the precision, safety, and comfort of procedures, concurrently reducing recovery periods and hospital stays. For example, in January 2024, Intuitive Surgical Inc., a US-based manufacturer of robotic products, reported that they had placed 415 da Vinci surgical systems (robotic surgical systems utilizing a minimally invasive approach) in the fourth quarter of 2023, signifying a 12% increase compared to 2022. Therefore, the expanding embrace of minimally invasive surgeries acts as a significant impetus for the balloon catheters market’s expansion.

How Is The Balloon Catheters Market Divided Into Its Major Segments?

The balloon catheters market covered in this report is segmented –

1) By Procedure Type: Percutaneous Transluminal Coronary Angioplasty (PTCA) Balloon Catheters, Chronic Total Occlusion (CTO) Balloon Catheters

2) By Product Type: Normal Balloon Catheter, Drug Eluting Balloon Catheter, Cutting Balloon Catheter, Stent Graft Balloon Catheter, Scoring Balloon Catheter

3) By Distribution Channel: Direct Tender, Third Party Distribution, Other Distribution Channels

4) By Application: Coronary Artery Disease, Peripheral Artery Disease, Other Applications

5) By End User: Hospitals, Specialty Centers, Ambulatory Surgery Centers, Other End Users

Subsegments:

1) By Percutaneous Transluminal Coronary Angioplasty (PTCA) Balloon Catheters: Semi-Compliant Balloon Catheters, Non-Compliant Balloon Catheters

2) By Chronic Total Occlusion (CTO) Balloon Catheters: High-Pressure CTO Balloon Catheters, Low-Profile CTO Balloon Catheters

What Trends Are Projected To Affect The Balloon Catheters Market?

Leading companies in the balloon catheters market are prioritizing the development of mechanical thrombectomy (MT) procedure solutions, with an aim to optimize blood clot removal through the localized management of blood flow during these interventions. Mechanical thrombectomy (MT) represents a minimally invasive medical technique utilized for extracting blood clots from blood vessels, most often in scenarios of ischemic stroke. For example, in September 2024, CERENOVUS, the neurovascular division of Johnson & Johnson Medical Devices Companies, unveiled the EMBOGUARD Balloon Guide Catheter in Europe. This apparatus is specifically engineered for endovascular procedures, including the treatment of acute ischemic stroke. The EMBOGUARD catheter enhances clot removal efficacy by locally regulating blood flow during mechanical thrombectomy procedures. Its deployment has been linked to improved first-pass recanalization rates, shorter procedure durations, and a reduced likelihood of clot fragments causing distal emboli, which can otherwise result in new ischemic events. The EMBOGUARD Balloon Guide Catheter is a key part of the CERENOVUS Stroke Solutions portfolio, a collection of technologies crafted to support physicians in executing mechanical thrombectomy procedures.

Who Are The Prominent Organizations Shaping The Balloon Catheters Market?

Major companies operating in the balloon catheters market are Cardinal Health Inc., Johnson & Johnson, Abbott Laboratories, Medtronic plc, Boston Scientific Corporation, Lepu Medical Technology, B. Braun Melsungen AG, Terumo Corporation, Teleflex Incorporated, Cook Medical Inc., Biotronik SE & Co. KG, Merit Medical Systems Inc., Asahi Intecc Co. Ltd., Freudenberg Medical LLC, Biomerics, AngioDynamics Inc., Endologix Inc., Raumedic AG, Otsuka Pharmaceutical Factory Inc., AngioScore Inc., CardioFlow, Endocor GmbH, MicroPort Scientific Corporation, Eureka Medical Inc., Neovasc Inc.

Read the full balloon catheters market report here:

https://www.thebusinessresearchcompany.com/report/balloon-catheters-global-market-report

What Are The Top-Performing Regions Within The Balloon Catheters Market?

North America was the largest region in the balloon catheters market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the balloon catheters market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Tailored Balloon Catheters Market Research Report For Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=20717&type=smp

Browse Through More Reports Similar to the Global Balloon Catheters Market 2026, By The Business Research Company

Rehabilitation Equipment Global Market Report

https://www.thebusinessresearchcompany.com/report/rehabilitation-equipment-global-market-report

Rehabilitation Robotics Global Market Report

https://www.thebusinessresearchcompany.com/report/rehabilitation-robotics-global-market-report

Medical Rehabilitation Services Global Market Report

https://www.thebusinessresearchcompany.com/report/medical-rehabilitation-services-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model